Wednesday, April 23, 2025

Yearly Archives: 2020

Coronavirus (COVID-19) Update: Daily Roundup May 4, 2020

May 04, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: A...

JEDI launches billion molecules against COVID19 challenge

May 05, 2020: "The Joint European Disruptive Initiative is launching on a global basis the JEDI Billion Molecules against Covid19 Grand Challenge. Stage...

Sanofi/Regeneron’s Libtayo® (cemiplimab) shows benefit in BCC

May 5, 2020: "Topline data for a pivotal, single-arm, open-label trial for Sanofi and Regeneron’s PD-1 inhibitor Libtayo® (cemiplimab) in patients with advanced basal...

Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome

May 05, 2020: "Shares in Newron Pharmaceuticals have taken a massive hit from the failure of sarizotan to show a clear benefit in patients...

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

May 4, 2020: "Menarini Group announced a definitive agreement under which Menarini Group will acquire Stemline in a transaction valued up to $677 million. Under the terms...

U.S. Targets Fraud in Coronavirus Antibody Test Market With Tighter Rules

May 4, 2020: "The United States on Monday began requiring antibody tests for the new coronavirus to undergo a regulatory agency review, acknowledging that...

EC approves label update for AstraZeneca’s Lokelma

May 04, 2020: "The European Commission (EC) has approved a dosing and administration label update in the EU for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) to include...

Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

May 03, 2020: "Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its new Elecsys® Anti-SARS-CoV-2...

CDC launches national viral genomics consortium to better map SARS-CoV-2 transmission

May 1, 2020: CDC has kicked off the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES) consortium, which will greatly expand the use...

Coronavirus (COVID-19) Update: Daily Roundup May 1, 2020

May 01, 2020: "The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today,...

Gilead’s Investigational Antiviral Remdesivir Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of COVID-19

May 1, 2020: Gilead Sciences, Inc. announced that the U.S FDA has granted emergency use authorization (EUA) for the investigational antiviral remdesivir to treat COVID-19. ...

Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

April 29, 2020: "Chimerix, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases announced the Company’s...
- Advertisment -

Most Read